Shares of Kodiak Sciences surged sharply on Thursday after the biotechnology company reported positive results from a late-stage study of its experimental drug for diabetic retinopathy, a diabetes-related eye condition. The stock jumped as much as 68.6% to its highest level in more than four years,
Analiz bekleniyor...
Analiz bekleniyor...
⭐⭐ (2/5)
Düşük